Porscha Johnson, Senior Oncology Medical Science Liaison at Johnson and Johnson Innovative Medicine, shared a post on LinkedIn:
“Two More days before our Live Interactive Molecular Tumor Board (MTB) at ASCO!!
Join our in-person breakfast session during ASCO to explore real-world applications of genomic profiling in cancer care!
Friday, May 30th | 8:30-11am CT
- Impact of comprehensive genomic profiling on therapeutic strategy
- Evolving classification of HER2-low and HER2-ultra-low disease
- Clinical application of ctDNA monitoring
- Emerging role of personalized cancer vaccines”
More posts featuring ASCO25.